Literature DB >> 30005017

Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1.

Christina C Chang1, Vivek Naranbhai2, Jared Stern3, Michael Roche3,4, Ashanti Dantanarayana3, Ruian Ke5, Surekha Tennakoon3, Ajantha Solomon3, Rebecca Hoh6, Wendy Hartogensis7, Frederick M Hecht8, Ken Sikaris9, David J Price3,10, Julian H Elliott1, Steven G Deeks6, Melissa Churchill4, Paul U Cameron1,3, Nicolas Hengartner5, Alan S Perelson5, Sharon R Lewin1,3.   

Abstract

OBJECTIVE(S): To determine whether variation in cell-associated unspliced (CA-US) HIV RNA in HIV-infected individuals on antiretroviral therapy (ART) has a circadian basis.
METHODS: Prospective observational study of HIV-infected individuals on ART. Blood was collected on three occasions and CA-US HIV RNA and mRNA of the circadian-locomotor-output-cycles-kaput (CLOCK)-associated genes quantified by real time PCR. CLOCK-associated proteins were over-expressed in a cell line stably transfected with an HIV long-terminal repeat (LTR) luciferase reporter.
RESULTS: Using a mixed effects model, there was a significant increase in log-CA-US RNA at the third visit compared with the first visit (effect size of 0.619 with standard error (SE) of 0.098, P < 0.001) and an independent effect of time of blood draw (effect size 0.051 (SE 0.025), P = 0.040). The CLOCK-associated gene, brain-and-muscle-ARNT-like-1 (BMAL-1) had a significant relationship with log CA-US HIV RNA (effect size 8.508 (SE 3.777), P = 0.028) and also with time (P = 0.045). Over expression of BMAL-1 and CLOCK in a cell line stably transfected with an HIV-LTR luciferase reporter resulted in an increase in luciferase expression and this was reduced following mutation of the second E-box in the HIV-LTR.
CONCLUSION: The basal level of HIV transcription on ART can vary significantly and is modulated by the circadian regulator BMAL-1, amongst other factors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30005017      PMCID: PMC6173794          DOI: 10.1097/QAD.0000000000001937

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  33 in total

1.  Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus.

Authors:  Ruth A Akhtar; Akhilesh B Reddy; Elizabeth S Maywood; Jonathan D Clayton; Verdun M King; Andrew G Smith; Timothy W Gant; Michael H Hastings; Charalambos P Kyriacou
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

2.  HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.

Authors:  Nancy M Archin; Rosalie Bateson; Manoj K Tripathy; Amanda M Crooks; Kuo-Hsiung Yang; Noelle P Dahl; Mary F Kearney; Elizabeth M Anderson; John M Coffin; Matthew C Strain; Douglas D Richman; Kevin R Robertson; Angela D Kashuba; Ronald J Bosch; Daria J Hazuda; Joann D Kuruc; Joseph J Eron; David M Margolis
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

3.  Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard
Journal:  Lancet HIV       Date:  2014-09-15       Impact factor: 12.767

4.  Hydrocortisone and some other hormones enhance the expression of HTLV-III.

Authors:  P D Markham; S Z Salahuddin; K Veren; S Orndorff; R C Gallo
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

5.  Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Authors:  S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Circadian regulator CLOCK is a histone acetyltransferase.

Authors:  Masao Doi; Jun Hirayama; Paolo Sassone-Corsi
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

7.  Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Authors:  Julian H Elliott; James H McMahon; Christina C Chang; Sulggi A Lee; Wendy Hartogensis; Namandje Bumpus; Rada Savic; Janine Roney; Rebecca Hoh; Ajantha Solomon; Michael Piatak; Robert J Gorelick; Jeff Lifson; Peter Bacchetti; Steven G Deeks; Sharon R Lewin
Journal:  Lancet HIV       Date:  2015-11-17       Impact factor: 12.767

8.  Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats.

Authors:  Lachlan R Gray; Daniel Cowley; Emma Crespan; Casey Welsh; Charlene Mackenzie; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-25       Impact factor: 2.205

9.  Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production.

Authors:  S W Cole; Y D Korin; J L Fahey; J A Zack
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

10.  Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Authors:  Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin
Journal:  PLoS Pathog       Date:  2014-11-13       Impact factor: 6.823

View more
  10 in total

1.  Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.

Authors:  Chia-Ching Wang; Cassandra Thanh; Erica A Gibson; Maya Ball-Burack; Louise E Hogan; Benjamin Descours; Norman Jones; Alexander B Carvidi; Sadie Munter; Sonia Bakkour; Michael P Busch; Jeffrey M Milush; Steven G Deeks; Timothy J Henrich
Journal:  Blood Adv       Date:  2018-12-11

Review 2.  Between a shock and a hard place: challenges and developments in HIV latency reversal.

Authors:  Jennifer M Zerbato; Harrison V Purves; Sharon R Lewin; Thomas A Rasmussen
Journal:  Curr Opin Virol       Date:  2019-04-29       Impact factor: 7.090

3.  Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.

Authors:  Steven A Yukl; Shahzada Khan; Tsui-Hua Chen; Martin Trapecar; Frank Wu; Guorui Xie; Sushama Telwatte; Daniel Fulop; Alexander R Pico; Gregory M Laird; Kristen D Ritter; Norman G Jones; Chuanyi M Lu; Robert F Siliciano; Nadia R Roan; Jeffrey M Milush; Ma Somsouk; Steven G Deeks; Peter W Hunt; Shomyseh Sanjabi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

4.  Circadian control of hepatitis B virus replication.

Authors:  Xiaodong Zhuang; Donall Forde; Senko Tsukuda; Valentina D'Arienzo; Laurent Mailly; James M Harris; Peter A C Wing; Helene Borrmann; Mirjam Schilling; Andrea Magri; Claudia Orbegozo Rubio; Robert J Maidstone; Mudassar Iqbal; Miguel Garzon; Rosalba Minisini; Mario Pirisi; Sam Butterworth; Peter Balfe; David W Ray; Koichi Watashi; Thomas F Baumert; Jane A McKeating
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

Review 5.  2018 international meeting of the Global Virus Network.

Authors:  Christian Brechot; Juliet Bryant; Hubert Endtz; Robert F Garry; Diane E Griffin; Sharon R Lewin; Natalia Mercer; Albert Osterhaus; Valentina Picot; Anders Vahlne; Georges M G M Verjans; Scott Weaver
Journal:  Antiviral Res       Date:  2019-01-25       Impact factor: 5.970

Review 6.  Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs.

Authors:  Amina Ait-Ammar; Anna Kula; Gilles Darcis; Roxane Verdikt; Stephane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Olivier Rohr; Carine Van Lint
Journal:  Front Microbiol       Date:  2020-01-24       Impact factor: 5.640

Review 7.  The Circadian Clock and Viral Infections.

Authors:  Helene Borrmann; Jane A McKeating; Xiaodong Zhuang
Journal:  J Biol Rhythms       Date:  2020-11-09       Impact factor: 3.182

Review 8.  The role of circadian clock pathways in viral replication.

Authors:  Xiaodong Zhuang; Rachel S Edgar; Jane A McKeating
Journal:  Semin Immunopathol       Date:  2022-02-22       Impact factor: 11.759

Review 9.  The role of latency reversal in HIV cure strategies.

Authors:  Kiho Tanaka; Youry Kim; Michael Roche; Sharon R Lewin
Journal:  J Med Primatol       Date:  2022-08-27       Impact factor: 0.821

10.  Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication.

Authors:  Helene Borrmann; Rhianna Davies; Matthew Dickinson; Isabela Pedroza-Pacheco; Mirjam Schilling; Alun Vaughan-Jackson; Andrea Magri; William James; Peter Balfe; Persephone Borrow; Jane A McKeating; Xiaodong Zhuang
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.